U.S. expansion on the horizon for Romanian health-tech startup, Medicai
Medicai, a Romanian company specializing in medical imaging software and infrastructure solutions, is actively seeking to expand its customer base in various countries, including Spain, Brazil, Germany, France, Austria, Saudi Arabia, Costa Rica, and the United States.
The company's expansion into the US market required an investment of approximately EUR 200,000. Medicai's US operations are supported by a team of one employee in Florida. The number of Medicai's US clients has increased from five to 25 in the past year, and the company expects to have more than 50 US clients by 2025, surpassing the number in Romania.
Medicai's growth in the US market is driven by the increasing adoption of technological innovations in the medical sector and the quick decision-making process of US customers. The company's management expects a significant growth in the US market, with a focus on increasing the number of clients and recurring revenue.
The Medicai platform acts as a versatile cloud-based PACS platform, connecting to various imaging equipment and allowing access via web or mobile app. It is used for teleradiology, multidisciplinary tumor boards, and optimizing radiologists' time interpreting imaging studies.
Impact of Federal Policies on Medicaid Expansion
While Medicai's growth through Medicaid expansion has been significant in providing millions of people with coverage, new federal laws effective from 2027 introduce requirements that will slow enrollment growth, increase churn, and significantly reduce federal Medicaid spending.
By January 1, 2027, states will be required to impose work requirements as a condition for Medicaid expansion eligibility and coverage, conduct eligibility redeterminations twice yearly for Medicaid expansion enrollees, limit retroactive Medicaid coverage from three months to one month for expansion enrollees, and impose mandatory cost-sharing (up to $35 per service) for certain Medicaid expansion adults.
These changes are expected to reduce federal Medicaid spending by tens of billions of dollars over the next decade, with the Congressional Budget Office estimating that work requirements and frequent redeterminations alone could reduce spending by approximately $62.5 billion over ten years. However, these cost savings come partly from increases in disenrollments and coverage losses, which may lead to higher uninsured rates and increased uncompensated care for hospitals and providers.
Medicai's Global Footprint
Currently, Medicai has 70 customers in Romania, the US, the UK, India, and other countries such as Spain, Brazil, Germany, France, Austria, Saudi Arabia, and Costa Rica. Medicai's clients often manage multiple locations or work with a large network of partners or suppliers.
Medicai was founded in 2019 by Mircea Popa (CEO), Alexandru Artimon (CTO), and Andrei Blaj (COO). The company is part of GapMinder Ventures' investment portfolio. Medicai currently employs 11 people in Romania and one person in Florida, US.
By the end of 2025, US revenues are expected to represent 50% of Medicai's business, up from 30% currently and 10% at the beginning of the year. Medicai's clients include healthcare providers, US attorneys specializing in personal injury or workers' compensation, veterinary clinics, companies offering industrial imaging services, and pharmaceutical/medical research companies.
In light of the new federal policies effective from 2027, Medicai's growth in the US market might face challenges due to work requirements, frequent eligibility redeterminations, and the imposition of cost-sharing, which could potentially lead to reduction in federal Medicaid spending and increase in uninsured rates. Although these changes may reduce spending by tens of billions of dollars over the next decade, they could also increase uncompensated care for hospitals and providers. On the other hand, the expanding US market provided an opportunity for Medicai, as the company saw an increase from 5 to 25 US clients in the past year, with expectations of surpassing the number in Romania by 2025. The growth in the US is driven by the adoption of technology in the medical sector and quick US customer decision-making, resulting in an expected 50% of Medicai's business deriving from the US by the end of 2025.
